More than 16,000 Americans die each year from prescription drug overdoses. According to the Centers for Disease Control and Prevention, such deaths have increased more than 300 percent since 1998, while prescribing rates for these drugs quadrupled between 1999 and 2010. Narcotic pain relievers—known as opioids—were involved in 75 percent of the nation’s drug overdoses. Deaths connected to opioid misuse now exceed those from heroin and cocaine combined.
Prescription drug abuse also takes a financial toll, with public and private insurers incurring an estimated $72.5 billion in costs each year because of direct drug costs and medical care that results from the misuse and abuse of opioids and other drugs. In fact, every dollar spent on these prescriptions generates an estimated $41 in related medical claims.1 Yet health insurers—particularly Medicare and Medicaid—have limited options for curtailing drug overuse and abuse, and physicians and pharmacists have few reliable tools to detect at-risk patients.
The Pew Charitable Trusts recognizes prescription drug abuse as a public health crisis in the United States that must be addressed. Pew’s prescription drug abuse project works to develop and support policies that will help reduce the inappropriate use of prescription drugs while ensuring that patients with legitimate medical needs have access to effective pain management.
On December 5, The Pew Charitable Trusts wrote a letter to Ways and Means Health Subcommittee Chairman Kevin Brady and Ranking Member Jim McDermott supporting language in the Protecting the Integrity of Medicare Act of 2014 that will allow Medicare Part D plan sponsors to use drug management programs for patients at risk of prescription drug abuse. Read More
Research cited in the Centers for Disease Control and Prevention’s Oct. 3 Morbidity and Mortality Weekly Report, examines whether the increasing number of deaths from heroin overdose in the United States are associated with the declining number of deaths from opioid pain relievers. Read More
On Friday, September 12, Pew submitted comments to the Office of National Drug Control Policy (ONDCP) regarding the development of the 2015 Drug Control Strategy. Read More